Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · IEX Real-Time Price · USD
6.18
+0.06 (1.06%)
Jul 22, 2024, 10:27 AM EDT - Market open
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for VNDA stock has a target of 11, which predicts an increase of 78.14% from the current stock price of 6.18.
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for VNDA is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $11 | Buy | Initiates | $11 | +78.14% | Jul 11, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $24 → $12 | Strong Buy → Hold | Downgrades | $24 → $12 | +94.33% | Feb 25, 2022 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 14, 2021 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Oct 29, 2020 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 9, 2020 |
Financial Forecast
Revenue This Year
198.39M
from 192.64M
Increased by 2.98%
Revenue Next Year
237.05M
from 198.39M
Increased by 19.49%
EPS This Year
-0.06
from 0.04
EPS Next Year
-0.34
from -0.06
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 204.2M | 244.0M | 159.7M |
| Avg | 198.4M | 237.1M | 155.1M |
| Low | 190.6M | 227.8M | 149.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 6.0% | 23.0% | -32.6% |
| Avg | 3.0% | 19.5% | -34.6% |
| Low | -1.1% | 14.8% | -37.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.06 | -0.35 | 0.14 |
| Avg | -0.06 | -0.34 | 0.13 |
| Low | -0.06 | -0.32 | 0.13 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.